Briefing
How real-world data is transforming GLP-1 research for diabetes and obestiy care
GLP-1 medications are revolutionizing the way we treat type 2 diabetes and obesity. Additionally, researchers are exploring GLP-1s for everything from treating addiction and lowering cardiovascular risk, to reducing knee pain. Understanding these diverse effects and optimizing GLP-1 therapies across patient populations is essential.
With Truveta Data, researchers gain access to RWD that provides comprehensive insights, addressing critical questions about the real-world performance of GLP-1 therapies.
Download the briefing for insight into:
- Comparative effectiveness of GLP-1 therapies
- Patient switching between GLP-1 medications
- GLP-1 medication patterns like adherence, side effects, and real-world durability